COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,861 Articles (22,568 medRxiv, 8,293 bioRxiv)

Most recent first Previous |  Page 2808: Articles 28071-28080  | Next

Simple ventilators for emergency use based on Bag-Valve pressing systems: Lessons learned and future steps
Castro-Camus, E., Ornik, J., Mach, C., Hernandez-Cardoso, G. G., Savalia, B., Taiber, J., Ruiz-Marquez, A., Kesper, K., Konde, S., Sommer, C., Wiener, J., Geisel, D., Huppe, F., Kraling, G., Nguyen, J., Wiesmann, T., Beutel, B., Koch, M.
10.1101/2020.04.29.20084749 — Posted: 2020-05-05
The Utility of rRT-PCR in Diagnosis and Assessment of Case-fatality rates of COVID-19 In the Iranian Population. Positive Test Results are a Marker for Illness Severity
Janbabaei, G., Brandt, E. J., Golpira, R., Raeisi, A., Sadegh Tabrizi, J., Safikhani, H. R., Talebian, M. T., Mirab Samiee, S., Biglar, A., Malekzadeh, R., Mani, A.
10.1101/2020.04.29.20085233 — Posted: 2020-05-05
Antibody Profiling and Prevalence in the US population during the SARS-CoV2 Pandemic
Krishnamurthy, H. K., Jayaraman, V., Krishna, K., Rajasekaran, K. E., Wang, T., Bei, K., Rajasekaran, J. J., Yaskin, I., Rai, A. J., Choung, R. S., Murray, J. A.
10.1101/2020.04.29.20085068 — Posted: 2020-05-05 Discussion: Onsite
How many lives can be saved? A global view on the impact of testing, herd immunity and demographics on COVID-19 fatality rates
Sanchez-Romero, M., di Lego, V., Prskawetz, A., L Queiroz, B.
10.1101/2020.04.29.20084400 — Posted: 2020-05-05
Group testing for SARS-CoV-2 allows for up to 10-fold efficiency increase across realistic scenarios and testing strategies
Verdun, C. M., Fuchs, T., Harar, P., Elbrächter, D., Fischer, D. S., Berner, J., Grohs, P., Theis, F. J., Krahmer, F.
10.1101/2020.04.30.20085290 — Posted: 2020-05-05 Discussion: Onsite
A Susceptible-Infected-Removed (SIR) model of COVID-19 epidemic trend in Malaysia under Movement Control Order (MCO) using a data fitting approach
Arifin, W. N., Chan, W. H., Amaran, S., Musa, K. I.
10.1101/2020.05.01.20084384 — Posted: 2020-05-05 Discussion: Onsite
A novel deterministic forecast model for COVID-19 epidemic based on a single ordinary integro-differential equation
Koehler-Rieper, F., Roehl, C. H. F., De Micheli, E.
10.1101/2020.04.29.20084376 — Posted: 2020-05-05
Epidemic Models for Personalised COVID-19 Isolation and Exit Policies Using Clinical Risk Predictions
Evgeniou, T., Fekom, M., Ovchinnikov, A., Porcher, R., Pouchol, C., Vayatis, N.
10.1101/2020.04.29.20084707 — Posted: 2020-05-05
Suppress, and not just flatten:Strategies for Rapid Suppression of COVID19 transmission in Small World Communities
Bhattacharyya, C., Vinay, V.
10.1101/2020.04.29.20085126 — Posted: 2020-05-05
Mathematical model describing CoViD-19 in Sao Paulo State, Brazil - Evaluating isolation as control mechanism and forecasting epidemiological scenarios of release
Yang, H. M., Lombardi Junior, L. P., Castro, F. F. M., Yang, A. C.
10.1101/2020.04.29.20084830 — Posted: 2020-05-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).